Respiratory Viruses and You

Angie SzumlinskiNews

Ugh, the flu season, it is back and predicted to be a more difficult year due to last year being relatively mild. If you have never had the flu, trust me, you don’t want to experience it. The body aches, fever, chills, sore throat, cough, difficulty breathing, oh and don’t forget the possible GI symptoms some people experience! Sounds great, …

CDC Stands Up – New Disease Forecasting Center

Angie SzumlinskiNews

Today, the Centers for Disease Control and Prevention (CDC) is announcing a new center designed to advance the use of forecasting and outbreak analytics in public health decision-making. Read about it on the CDC website here:

CDC Statement on Recommendation for an Additional Dose of COVID-19 Vaccine in Moderately to Severely Immunocompromised People

Angie SzumlinskiNews

This official CDC recommendation — which follows FDA’s decision to amend the emergency use authorizations of the vaccines — is an important step in ensuring everyone, including those most vulnerable to COVID-19, can get as much protection as possible from COVID-19 vaccination.

ACIP Altered Immunocompetence Guidelines for Immunizations

Angie SzumlinskiNews

This section incorporates general content from the Infectious Diseases Society of America policy statement, 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host (1), to which CDC provided input in November 2011. The evidence supporting this guidance is based on expert opinion and arrived at by consensus.

Multistate Investigation of Non-travel Associated Burkholderia pseudomallei Infections (Melioidosis) in Four Patients

Angie SzumlinskiStudies

The Georgia Department of Public Health, with assistance from the Centers for Disease Control and Prevention (CDC), is investigating a fatal case of Burkholderia pseudomallei infection (i.e., melioidosis) identified in late July 2021. Based on genomic analysis, this case in Georgia closely matches the three cases previously identified in Kansas, Minnesota, and Texas in 2021, indicating they all most likely share a …

Several LeadCare Blood Lead Tests Recalled

Angie SzumlinskiAnnouncements

On July 1, 2021, the U.S. Food and Drug Administration (FDA) issued a notice that Magellan Diagnostics, Inc., is recalling its LeadCare II, LeadCare Plus, and LeadCare Ultra Blood Lead Tests due to a significant risk of falsely low results. FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious …